MARKET

HUMDF

HUMDF

Hua Medicine Cay
OTCPK
0.411
NaN%
Closed 09:30 12/26 EST
OPEN
--
PREV CLOSE
0.411
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.411
52 WEEK LOW
0.150
MARKET CAP
433.95M
P/E (TTM)
2.716
1D
5D
1M
3M
1Y
5Y
1D
Hua Medicine Advances Diabetes Treatment with New Phase Ib Trial
TipRanks · 12/09 12:09
Hua Medicine Grants Share Options to Drive Growth and Commitment
TipRanks · 12/01 00:37
Hua Medicine Announces Changes to Remuneration Committee
TipRanks · 11/27 10:12
Hua Medicine Updates Board of Directors and Committee Roles
TipRanks · 11/27 10:10
Weekly Report: what happened at HUMDF last week (0908-0912)?
Weekly Report · 09/15 09:46
Weekly Report: what happened at HUMDF last week (0901-0905)?
Weekly Report · 09/08 09:48
Weekly Report: what happened at HUMDF last week (0825-0829)?
Weekly Report · 09/01 09:46
Hua Medicine Reports Strong Growth in 2025
TipRanks · 08/29 03:54
More
About HUMDF
Hua Medicine is an investment holding company primarily engaged in the development and commercialization of oral drug for the treatment of Type 2 diabetes. The Company is also engaged in the commercialization of HuaTangNing products. The Company’s main product pipeline dorzagliatin or HMS5552 is a glucokinase activator or GKA, designed to control the progressive degenerative nature of diabetes by restoring glucose homeostasis in Type 2 diabetes. The Company mainly conducts its businesses in the domestic market.

Webull offers Hua Medicine stock information, including OTCPK: HUMDF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HUMDF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HUMDF stock methods without spending real money on the virtual paper trading platform.